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ParamyxovirusDuring replication of human parainﬂuenza virus type 3 (HPIV3), the 96-nucleotide antigenomic promoter
(AGP) of HPIV3 directs the synthesis of genomic RNA. Previous work showed that nucleotides 1–12 were
critical in promoting replication of an HPIV3 minireplicon, but nucleotides 13–96 were not investigated. In
this study, the role of nucleotides 13–96 in AGP function was analyzed by creating and assaying mutations in
an HPIV3 minireplicon. A replication promoting element known as promoter element II (nt 79–96) was
conﬁrmed in the HPIV3 AGP. Additionally, nucleotides 13–39 were found to constitute an additional positive-
acting cis-element. However, detailed analysis of the 13–39 element revealed a complicated control element
with both stimulatory and repressing elements. Speciﬁcally, nucleotides 21–28 were shown to repress RNA
replication, while ﬂanking sequences had a stimulatory effect.fman).
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Human parainﬂuenza virus type 3 (HPIV3) is an enveloped,
nonsegmented, negative-sense RNA virus within the Respirovirus
genus of the subfamily Paramyxovirinae, family Paramyxoviridae, order
Mononegavirales (Lamb and Parks, 2007). As with other parainﬂuenza
viruses, HPIV3 is a signiﬁcant cause of lower respiratory tract infections,
most notably pneumonia andbronchiolitis in infants and young children
(Cilla et al., 2008; Henrickson et al., 2004; Karron and Collins, 2007).
HPIV3 can also cause serious respiratory illness in elderly, immunocom-
promised, and chronically ill individuals (Henrickson, 2003; Jalal et al.,
2007; Loeb et al., 2000; Nichols et al., 2004; Piralla et al., 2009).
During the infection cycle of mononegaviruses, the viral genome,
which is encapsidated by the nucleocapsid (N) protein, serves as the
template for viral RNA replication. The RNA-dependent RNA poly-
merase (RDRP), composed of the viral P and L proteins, binds to the
extreme 3′ end of the genome and produces an encapsidated, full-
length antigenome. This antigenomic RNA then functions as the
template for synthesis of progeny viral genomeswhen the RDRP binds
the 3′ end of the antigenome (Lamb and Parks, 2007).
The 3′ ends of the genomic and antigenomic RNAs contain all
sequences necessary for genome replication and are referred to as the
genomic and antigenomic promoters, GP and AGP, respectively.Features of these replication promoters vary among the different
families and subfamilies of the Mononegavirales. For the Paramyxovir-
inae, which includes members of the Respirovirus (HPIV3 and Sendai
virus [SeV]), Morbillivirus (measles virus), Rubulavirus (parainﬂuenza
virus 5 [PIV5]), and Henipavirus (Nipah virus [NiV]) genera, common
features important for RNA replication include multiple cis-elements,
proper spacing between these cis-elements, and adherence to the rule of
six (Lamb and Parks, 2007; Whelan et al., 2004).
Two critical cis-elements have been identiﬁed in the replication
promoters of all members of the Paramyxovirinae studied to date:
promoter element I (PrE-I) and promoter element II (PrE-II) (Hoffman
and Banerjee, 2000b; Murphy and Parks, 1999; Tapparel et al., 1998;
Walpita, 2004; Walpita and Peters, 2007). The exact position and
sequence composition of these critical regions vary among the genera.
Promoter element I is present at the 3′ terminus of the genomic and
antigenomic promoters and in HPIV3 consists of the 3′ terminal 12
nucleotides. Most nucleotides in PrE-I are highly conserved, and when
mutated, result in severe (1–3% of wild-type) reductions in replication
(Hoffman and Banerjee, 2000b). The second critical element, PrE-II, is
present 79–96 nucleotides from the 3′ terminus and, in HPIV3 and
SeV, consists of a repeated 3′[CNNNNN]3 motif. The critical nature of
this sequence motif has been conﬁrmed in the HPIV3 GP, but not in
the HPIV3 AGP. In this study, we conﬁrm the critical nature of PrE-II in
the HPIV3 AGP.
Another factor affecting replication within the Paramyxovirinae is
the rule of six. The rule of six is a requirement that the total nucleotide
length of a genome be a multiple of six for the genome to serve as a
functional template for replication. This rule appears to apply to all
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1997; Halpin et al., 2004; Murphy and Parks, 1997; Rager et al., 2002),
but was initially developed based on two ﬁndings with SeV. First,
examination of the helical SeV N-RNA by electron microscopy led to an
estimate that individual N proteins encapsidate six nucleotides each
(Egelman et al., 1989). Second, any non-hexameric disruption of the
genome length (by insertion or deletion) led to disruption of replication
(Calain andRoux, 1993). Since the RDRP recognizes the 3′ ends of theGP
and AGP in the context of bound N protein, precise encapsidation of the
3′ ends is thought to be essential for replication initiation (Vulliemoz and
Roux, 2001). Non-hexameric insertions or deletions within the genome
would disrupt the positioning of N proteins on PrE-I and/or PrE-II,
creating a misalignment that may lead to the N-RNA not being
recognized as a template for genome replication.
The spacing between PrE-I and PrE-II is also important. Insertions
or deletions that alter the natural spacing result in signiﬁcant
reductions in replication (Murphy et al., 1998; Tapparel et al., 1998).
Combining the three-dimensional structure of the N-RNA and the
rule of six may explain this requirement. Thirteen N protein subunits
are estimated to be contained in each turn of the helical SeV N-RNA
complex (Egelman et al., 1989), placing PRE-I (in hexamers 1 and 2)
and PrE-II (in hexamers 14, 15, and 16) on the same face of the helix.
The conserved and mutation sensitive nature of these sequences and
their positions on the N-RNA complex suggest that PrE-I and/or PrE-II
may serve as recognition sites for the RDRP. It is also possible that
cellular factors could bind PrE-I and/or PRE-II and help in the
recruitment of the RDRP to the template.
Sequences between PrE-I and PrE-II have also been shown to have
roles in RNA replication. In the Paramyxovirinae the PrE-I and PrE-II
elements are highly conserved or identical (as in HPV3) in their
respective genomic and antigenomic promoters, yet the AGP is the
stronger promoter. Thus, sequences outside of the two critical
promoter elements must inﬂuence promoter strength (Hoffman et
al., 2006; Keller et al., 2001; Tapparel and Roux, 1996; Walpita and
Peters, 2007). Sequences between PrE-I and PrE-II appear to enhance
RNA replication, but are not absolutely required for RNA synthesis.
One such cis-element spans nucleotides 13–28 of the HPIV3 GP
(Hoffman et al., 2006). This element enhances genome replication, but
is distinct from PrE-I as single base mutations within the GP 13–28
element do not signiﬁcantly impact genome replication. A signiﬁcant
decrease in replication was seen only when eight or more nucleotides
were mutated within the element. The only other deﬁned cis-element
between PrE-I and II shown to contribute to genome replication of the
Paramyxovirinae was found at nucleotides 51–66 in the AGP of PIV5
(Keller et al., 2001). This element displayed properties similar to the
HPIV3 GP 13–28 element in that this sequence enhances, but is not
critical for, genome replication.
In this study, we have completed the mapping of the replication
promoters of HPIV3 through detailed mutagenic analysis of AGP
nucleotides 13–96. In addition to conﬁrming the existence of PrE-II in
the HPIV3 AGP, we also identify a cis-element comprised of AGP
nucleotides 13–39 that appears to be analogous to the GP 13–28MG(-) KONGS 
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Fig. 1. Analysis of mutations of nucleotides 79, 85, and 91 in the antigenomic promoter of HPI
minigenomes were analyzed by primer extension. Genomic RNA was detected with a pos
Averages were based on three or more experiments with each mutant. Lanes marked— L ind
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Results
Role of HPIV3 AGP nucleotides 79, 85, and 91 in RNA replication
To analyze their role in genome replication, AGP nucleotides 79, 85,
and 91, predicted to be critical nucleotides in PrE-II, were individually
mutated inHPIV3minireplicon plasmids (Fig. 1). A previously described
minireplicon, MG(−) KONGS, in which the N gene start signal is
disrupted and transcription is eliminated (Hoffman and Banerjee,
2000b),was used as the parental plasmid formutagenesis of the AGP for
two reasons. First, minigenome replication in MG(−) KONGS is slightly
enhanced in this construct, facilitating detection of RNA replication
products. Second, some of the AGP mutations overlap the L gene stop
signal,which is present at nucleotides 45–56 of theAGP. Suchmutations
would have defects in transcription termination, thus potentially
confounding the effects of the mutations on replication. Minireplicon
mutantswere transfected (alongwith support plasmids encoding theN,
P, and L proteins) into HeLa cells infected with a recombinant vaccinia
virus encoding T7 RNA polymerase. After 48 h, cell lysates were treated
withmicrococcal nuclease to reduce the background of unencapsidated
RNA for analysis of replication products. Undigested RNA was then
extracted from the nuclease-treated lysates for analysis by primer
extension. Replication efﬁciency for a given mutant was expressed as a
ratio of the amount of genomic RNA relative to the amount of
antigenomic RNA (termed AGP activity).
Analysis of point mutations of nucleotides 79, 85, and 91
conﬁrmed the presence of a functional PrE-II in the AGP of HPIV3.
Mutation of AGP nucleotides 85 and 91 resulted in severe (10% WT
AGP activity or less) reductions in RNA synthesis, suggesting that
these nucleotides are critical for genome replication, and consistent
with observations from mutagenesis of nucleotides 85 and 91 of the
HPIV3 GP. Surprisingly, mutation of AGP nucleotide 79 resulted in
only a slight reduction in replication compared to WT (Fig. 1). This
contrasts with the analysis of PrE-II in the HPIV3 GP, in which
mutation of GP nucleotide 79 of a transcription-competent HPIV3
minireplicon resulted in reporter gene expression at 25% of wild-type
levels (Hoffman and Banerjee, 2000b).
Analysis of antigenomic promoter nucleotides 13–78 in replication
To clarify the role of AGP nucleotides 13–78 in replication, a series
of mutations which collectively span the AGP 13–78 region were
introduced into MG(−) KONGS (Fig. 2). In these mutants, targeted
sequences were scrambled to preserve the original base composition.
Mutation of AGP nucleotides 13–28 and 29–39 resulted in signiﬁ-
cantly reduced AGP activity, suggesting the presence of a cis-element
in this region. Mutation of nucleotides 40–50 and 51–66 did not
signiﬁcantly affect replication, while mutation of nucleotides 67–78
had a relatively minor effect on replication.-
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Fig. 2. Scanning mutagenesis of nucleotides 13–78 of the antigenomic promoter of HPIV3. Micrococcal nuclease-treated RNA extracts from cells transfected with the indicated
minigenomes were analyzed by primer extension. Genomic RNA was detected with a positive-sense primer, and antigenomic RNA was detected with a negative-sense primer.
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minigenome. (A) Sequences of scanning mutations in the 13–78 region compared to wild-type MG(−) KONGS. (B) Representative primer extension experiment of mutations in the
13–78 region. G-RNA and AG-RNA indicate genomic and antigenomic RNA, respectively, and SD indicates standard deviation.
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recognized as involved in directing the synthesis of genomic RNA, as
several point mutations in this region did not have a signiﬁcant
impact on AGP activity (Hoffman and Banerjee, 2000b). To more
precisely characterize this region and be able to compare mutants of
this region with previous analysis of the HPIV3 GP, we made
additional 4-base mutations spanning this region (Fig. 3). AGP activity
was signiﬁcantly reduced in mutants in which nucleotides 13–16, 17–
20, and 29–32 were altered. Interestingly, one mutation, 21–24,
signiﬁcantly (~2.5-fold) enhanced AGP activity. These ﬁndings
contrast with the results of previous analysis of the GP 13–28
element, in which no 4-nucleotide mutation showed a signiﬁcant
deleterious effect (Hoffman et al., 2006). In the GP, it was only when
eight or more nucleotides were altered that a substantial decrease in
RNA synthesis was observed. Thus, it appears that the AGP 13–39
region is more sensitive to mutation than the GP 13–28 region. It is
also notable that with the mutants that did show signiﬁcantly
diminished AGP activity (13–16, 17–20, 29–32), the decreased AGP
activity was not due solely to less synthesis of the genomic RNA.
Rather, in addition to the decreased synthesis of genomic RNA, there
was also a slight increase in antigenomic RNA synthesis.
Mapping the 5′ end of the 13–39 element
Since the 33–36 and 37–40 mutants did not signiﬁcantly impact
replication, we sought to more precisely deﬁne the 5′ end of the AGP
13–39 element. A series of mutants were created that progressively
mutated into the 13–39 element from the 5′ end (Fig. 4). Mutation ofMG(-) KONGS 
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signiﬁcantly reduce RNA synthesis. Extensions of this mutant by four
and eight nucleotides, covering nucleotides 36–43 and 32–43,
respectively, resulted in severe reductions in RNA synthesis. These
results conﬁrmed that the 5' end of this element mapped to
nucleotides 36–39. Surprisingly, an additional 4-nucleotide extension
of the mutation (mutant 28–43) showed a 10-fold improvement in
AGP activity, from about 6% activity with the 36–43 and 32–43
mutants to 64% with the 28–43 mutant. This was puzzling given that
several overlapping mutants (32–43, 36–43, 13–28, 29–39, and 29–
32) showed low AGP activity. It is worth reminding, however, that
mutants 21–24 and, to a lesser degree 25–28, resulted in enhanced
AGP activity (Fig. 3).
There were several potential explanations for the increased
replication of the AGP 28–43 mutant relative to the other mutants.
It was possible that the 28–43 mutant, by chance, created a
replication-promoting stimulatory sequence. It was also possible
that the 28–43 mutant disrupted a WT sequence that repressed AGP
activity. To discern these possibilities, we focused our analysis on
bases 28–31 as these were the only bases altered when comparing the
32–43 mutant with poor AGP activity to the 28–43 mutant with
restored AGP activity.
We began by swapping sequences between the 28–43 (restored
AGP activity) and the 29–32 (low AGP activity) mutants. It should be
noted that the sequence alterations in the 29–32 mutant (Fig. 3)
differed from those in the 28–43 mutant (Fig. 4). If the sequence of
bases 29–32 was responsible for the restored AGP activity of the 28–43
mutant and the low AGP activity in the 29–32 mutant, swapping thoseP activity 
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29–32 mutant (29–32 #2), in which the 29–32 mutation matched the
sequence changes found in 28–43, did replicate better than the original
29–32 mutant (Fig. 5). However, it did not replicate better that WT, as
would be expected if the 29–32 sequence from 28-43 had a stimulatory
effect. Insertion of the 29–32 sequence from the original 29–32mutant
into the 28–43mutant (to create 28–43 #2) did not reduce the restored
AGP activity of the 28–43 mutant. We were surprised by these resultsMG(-) KONGS 
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of HPIV3. Micrococcal nuclease-treated RNA extracts from cells transfected with the
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28–43 mutants. Therefore, additional 29–32 and 28–43 mutants (29–
32 #3 and 28–43 #3) were created. Each of these mutants had AGP
activities similar to that of the original 29–32 and 28–43 mutants
(Fig. 5), conﬁrming the phenotypes of the original mutants.
Satisﬁed that the phenotypic difference between the original 29–
32 and 28–43 mutants was not due to a gain in activity produced by
the 29–32 sequence in 28–43, we turned our attention to nucleotide
28. This position was altered in the 28–43 mutants with restored AGP
activity, but remained WT in the 29–32 and 32–43 mutants with low
AGP activity. It was possible that WT nucleotide 28, either alone or in
combination with the surrounding sequence, repressed AGP activity.
Thus, mutation of this sequence would disrupt the repressing signal
and result in increased replication efﬁciency. To test this, two
additional mutants were constructed, a point mutant of nucleotide
28 (A28C) and a mutant in which bases 28–32 were altered (28–32).
The 28–32 mutant extended the mutagenic region of the 29–32 #2
mutant to nucleotide 28, creating the same mutation sequence as in
the original 28–43 mutant. Surprisingly, mutation of nucleotide 28
alone resulted in the highest AGP activity of all the mutants analyzed
in this study (Fig. 5, lane 9), strongly implicating this nucleotide as a
repressor of genome replication. The 28–32 mutant, in which the
A28C change is added to the 29–32 #2 mutant, also resulted in
increased AGP activity, in this case approximately 3-fold (Fig. 5, lane
10 compared with lane 4). Thus, it appears that mutation of
nucleotide 28 is responsible for the high level of AGP activity seen
in the original 28–43 mutant.
Discussion
The extensive mutagenic analysis of the HPIV3 AGP completes the
mapping of the HPIV3 replication promoters and makes them the
most thoroughly mapped promoters of the Paramyxovirinae. This
allows for direct comparison of the genomic and antigenomic
promoters of HPIV3, and for comparison to promoters of other
members of the genus and subfamily.
Characterization of promoter element II in the HPIV3
antigenomic promoter
Promoter element II, one of two critical elements in promoting
genome replication of the Paramyxovirinae, is an internal element
consisting of three hexameric subunits in which the ﬁrst nucleotide
must be a C residue for the respiroviruses, as in: (CNNNNN)3. In this
study, point mutants of AGP nucleotides 79, 85, and 91 conﬁrmed that
a functional PrE-II exists in the HPIV3 AGP.
Comparison of the PrE-II elements of the HPIV3 genomic and
antigenomic promoters reveals broad similarities and subtle differ-
ences. In both promoters nucleotides 85 and 91 are critical for
replication while nucleotide 79 is less critical (Hoffman and Banerjee,
2000b). However, altering nucleotide 79 of the AGP resulted in only a
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nucleotide 79 resulted in signiﬁcant reduction (25% of wt). In
agreement with this observation, nucleotide selection experiments
within the AGP PrE-II of SeV showed that some substitutions at
nucleotide 79 were tolerated, but no substitutions were tolerated at
positions 85 or 91 (Tapparel et al., 1998). Thus, for the respiroviruses
it appears that AGP nucleotide 79 of PrE-II is less critical for promoting
replication than nucleotides 85 and 91.The HPIV3 AGP 13–39 element
In the HPIV3 AGP, nucleotides 13–78 constitute the region
between PrE-I and PrE-II. The signiﬁcance of this region in directing
RNA replication had not been studied in detail previously, but was
expected to be similar to the thoroughly-characterized HPIV3 GP, in
which a cis-element comprising nucleotides 13–28 is important for GP
activity (Hoffman et al., 2006). Indeed, analysis of the AGP 13–78
region revealed a promoter element spanning nucleotides 13–39 as
important for AGP activity. As with the GP 13–28 replication element,
the AGP 13–39 element appears to be distinct from PrE-I. Point
mutations in PrE-I of the AGP severely disrupted replication while
point mutations in the 13–39 region caused no signiﬁcant decrease in
replication (Hoffman and Banerjee, 2000b). Only when mutations of
four or more bases in the AGP 13–39 region were made (in this study)
did a replication deﬁcit become obvious. Additionally, themost severe
of the 13–39 mutations reduced replication to 5–10% of wild-type,
whereas most point mutations in the AGP PrE-I reduced replication to
b2% of wild-type. Thus, the 13–28 and 13–39 elements of the genomic
and antigenomic promoters are thought to enhance, but are not
essential for RNA replication. Due to the similarities between the 13–
28 and 13–39 elements of the GP and AGP, and their distinctiveness
from PrE-I and PrE-II, we propose designating these elements PrE-III.
This designation must be tentative as the presence of such elements
has not been conﬁrmed in other genera of the Paramyxovirinae.
Still, our ﬁnding that an important replication control element
exists in the 13–39 region of the HPIV3 AGP is in agreement with
previous work with SeV. Substitution of SeV AGP bases 1 to 31, but not
shorter segments, into the SeV GP conferred a high replication
phenotype to the GP and indicated a role for bases beyond PrE-I in
replication (Calain and Roux, 1995). In contrast, mutations adjacent to
PrE-I in the PIV5 AGP did not reveal an important control element
(Keller et al., 2001; Murphy et al., 1998). However, a replication-
promoting element was found at bases 51–66 in the PIV5 AGP (Keller
et al., 2001). It is possible that the HPIV3 PrE-III is analogous to the 51–
66 element of PIV5. The two elements are similar in that they are not
highly conserved and do not appear to be as critical for replication as
PrE-I and PrE-II. While their locations in their respective promoters is
different, it was shown that the 51–66 element can be moved and
retain function. Thus, it is possible that the HPIV3 PrE-III is a relocated
51–66 element.
The AGP 13–39 element, while promoting replication overall,
differs from the 13–28 element of the HPIV3 GP (and PrE-I and PrE-II)
by containing segments that repress promoter activity. Mutation of
bases 21–24 and nucleotide 28 both caused signiﬁcantly enhanced
AGP activity. The effect of changing nucleotide 28 was especially
dramatic, as every mutant in which nucleotide 28 was altered (25–28,
28–43, A28C, 28–32) had increased AGP activity. Thus, there appears
to be a speciﬁc segment (nucleotides 21–28) within the 13–39
element of the AGP that suppresses activity of the wild-type AGP. No
such negative acting regions have been deﬁned in the AGPs of other
paramyxoviruses. Negative acting elements have been broadly
mapped in the genomic promoters of SeV and PIV5 in sequences
ﬂanking PrE-I (bases 24–55 and 20–50, respectively) (Keller and
Parks, 2003) (Calain and Roux, 1995), but more precise deﬁnition of
negative acting domains has not been done. The presence of anegative-acting element in the GP makes sense since the GP is a
weaker promoter than the AGP.
For the HPIV3 AGP 13–39 element, the negative and positive-
acting cis-elements may reﬂect a ﬁne-tuning of the balance between
AGP activity (genomic RNA synthesis) and GP activity (antigenomic
RNA synthesis and transcription). The importance of striking the
correct balance in gene expression was illustrated when Manuse and
Parks (Manuse and Parks, 2009) characterized mutations from a
naturally occurring PIV5 variant. A recombinant virus carrying two
changes in PrE-I from the GP of the variant exhibited greater viral
transcription and gene expression, but elicited a stronger innate
immune response and more cellular toxicity compared to the wild-
type virus.
The PIV5 example and our data with the HPIV3 promoters also
illustrate the potential ease with which paramyxoviruses may adapt
to different conditions. Since subtle changes in the promoters can
have signiﬁcant impact on gene expression and/or the balance
between genome and antigenone synthesis, selection of such changes
may allow these viruses some ability to adapt to replicating at
different temperatures, in different cell types or even in different
species. We should note however, that because promoter:polymerase
ratios may be different in the minireplicon system compared to
natural infections, there may also be differences in the competition
between promoters. Thus, it will be important to check the balance of
genome to antigenome synthesis by analyzing AGP mutations in the
viral context.
How the 13–28 and 13–39 regions function to promote HPIV3
replication is not known, though several mechanisms are possible.
Increased terminal complementarity of promoter sequences has been
found to contribute to increased replication efﬁciency in vesicular
stomatitis virus (Wertz et al., 1994). This was thought to be due to
increased interaction of the genomic termini, which could enhance
recognition of the promoter sequences by the RDRP. Past analysis that
reduced the terminal complementarity of 17 nucleotides between the
natural HPIV promoters revealed no correlation between the degree
of natural terminal complementarity and replication efﬁciency
(Hoffman and Banerjee, 2000a). Still, a possible correlation between
changes in the 13–39 element, the degree of terminal complemen-
tarity and AGP activity was explored. Examination of terminal
complementarity between the GP and mutant AGP sequences
revealed no correlation between replication efﬁciency and the extent
of potential base-pairing between these regions (data not shown),
indicating that the primary nucleotide sequences are responsible for
observed replication phenotypes and not the degree of terminal
complementarity.
It is possible that the 13–28 and 13–39 regions could be important
as binding sites for viral and/or cellular proteins that promote binding
of the RDRP or other factors to the promoter. From prior sequence
analysis we knew that the region between PrE-I and PrE-II was poorly
conserved, making it difﬁcult to envision PrE-III as a binding site for
speciﬁc viral or cellular proteins. However, given the fairly precise
mapping completed in this paper we reexamined the conservation of
the 13–39 region. Sequence comparison of the AGPs of members of
the Respirovirus genus conﬁrms that there is remarkably little
conservation in the 13–39 region (Fig. 6). Notably however,
nucleotide 28 is identical in all viruses, perhaps pointing to a
conservation of the replication-suppressing function at this position
in the life cycle of these viruses. Overall though, given the lack of
sequence conservation it is hard to conceive of the 13–39 element, or
sub-region thereof, as a sequence-speciﬁc binding site for viral or
cellular proteins.
It is quite possible that PrE-III functions as a nucleation site for
encapsidation of the nascent RNAs produced during genome replica-
tion. Encapsidation occurs soon after the RDRP initiates RNA replication
and is thought to involve the RDRP binding the N protein and placing it
on the nascent RNA (Lamb and Parks, 2007). With RSV, sequences
HPIV3
SwinePIV3
HPIV1
SeV
Consensus
Fig. 6. Alignment of the terminal 44 nucleotides from the antigenomic promoters of members of the Respirovirus genus. Viruses included are: HPIV1 and 3 (GenBank: NC_003461 and
GenBank: Z11575.1 respectively), Swine PIV3 (GenBank: EU439429) and Sendai virus (GenBank: NC_001552.1). Base 1 is the 3′ terminal base of the antigenome. Capitalized
sequences in the consensus line (bold) indicate identical sequences; R and Y indicate conservative substitutions (Y = purine, R = pyrimidine). Dashes represent sequences not
conserved within the genus.
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encapsidation efﬁciency and processivity of the RDRP during replication
(McGivern et al., 2005). It is possible that the placement of N protein on
the nascent RNA by the RDRP may occur with minimal sequence
speciﬁcity, but if thePrE-III sequence is suboptimal thenencapsidation is
inefﬁcient, which leads to the termination of RNA synthesis.
The mapping and identiﬁcation of cis-elements within the
genomic and antigenomic promoters are important for the elucida-
tion of the detailed molecular mechanism of RNA replication in HPIV3
and related viruses. Currently we are analyzing recombinant viruses
with mutations in promoter elements to conﬁrm results with the
minigenome system, to better deﬁne sequence requirements, and to
better understand the mechanism of genome replication initiation.Materials and methods
Plasmid construction
Construction of the HPIV3 minireplicon pHPIV3 MG(−) has been
described previously (Hoffman and Banerjee, 2000b). The T7 RNA
polymerase transcript produced from pHPIV3 MG(−) contains 97
nucleotides from the 5′ terminus of the genome, a negative-sense
copy of the luciferase gene, 91 nucleotides from the 3′ terminus of the
genome, and the antigenomic hepatitis delta virus ribozyme gene. To
facilitate detection of viral replication products, a construct in which
the N gene start signal was disrupted in pHPIV3MG(−) (Hoffman and
Banerjee, 2000b), termed pHPIV3 MG(−) KONGS (Knock Out N Gene
Start), served as the parental vector for creating mutations in the AGP.
Mutations in pHPIV3 MG(−) KONGS were created by megaprimer
PCR-directed mutagenesis (Sarkar and Sommer, 1990). Megaprimer
PCR products containing mutations were digested with EcoRI and
HindIII and ligated into the same sites of pHPIV3 MG(−) KONGS. All
mutations were conﬁrmed by sequencing.Transfection
HeLa cell monolayers were grown in 6-well plates to 90%
conﬂuence and infected with the recombinant vaccinia virus vTF7-
3, which expresses T7 RNA polymerase, at a multiplicity of infection
of 5. After 1 h at 35 °C, the minireplicon and support plasmids
encoding HPIV3 N, P, and L genes were transfected into the infected
HeLa cells using Lipofectamine LTX with Plus reagent (Invitrogen)
according to the manufacturer's instructions, with the following
exception: 2.5 μl of Plus reagent and 2.5 μl of Lipofectamine LTX
were used per well transfected. The plasmid amounts per transfec-
tion were: 1.2 μg of pHPIV3 MG(−) KONGS, 0.2 μg of pHPIV3 N,
0.2 μg pHPIV3 P, and 0.195 μg of pHPIV3 L. At 24 hours post-
transfection, the transfection medium was removed and replaced
with 1.4 ml of Opti-MEM (Invitrogen) containing actinomycin D
(2 μg/ml) and 5% FBS.RNA isolation
Replication-speciﬁc RNA products from transfected HeLa cell
lysates were treated with micrococcal nuclease (NEB) at 48 hours
post-transfection as described previously (Durbin et al., 1997). The
nuclease-resistant RNA was then extracted via TRIzol (Invitrogen).
Primer extension analysis
Genomic RNA was detected using a [γ-32P]ATP-labeled oligomer
(5′-AGAGATCCTCATAAAGGCCAAG-3′) that primes at nucleotide 33 of
the luciferase gene and is extended 123 nucleotides to the 5′ end of
the genomic RNA. Antigenomic RNA was detected using an end-
labeled oligomer (5′-TTCTTTATGTTTTTGGCGTC-3′) that primes at
nucleotide 1656 of the luciferase gene and is extended 105
nucleotides to the 5′ end of the antigenomic RNA. These primers
were used with 20% of the nuclease-treated extracts in standard
reverse transcription reactions with Moloney murine leukemia virus
reverse transcriptase (New England Biolabs) at 44 °C for 45 min. The
extension products were separated on a 6% acrylamide-7 M urea gel
and analyzed on a Storm Model 860 PhosphorImager using Image-
Quant software.
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